about
Microarray gene expression profiling and analysis in renal cell carcinomaSystematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis.Pathway analysis of primary central nervous system lymphoma.Proteomics in renal research.Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma.Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury.Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues.Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues.Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism.Biochemical and molecular markers in renal cell carcinoma: an update and future prospects.From bench to bedside: current and future applications of molecular profiling in renal cell carcinomaαB-crystallin: Portrait of a malignant chaperone as a cancer therapeutic targetQuantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.Pivotal role of augmented αB-crystallin in tumor development induced by deficient TSC1/2 complex.Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins.HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins.Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels.Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma.Chaperone-independent mitochondrial translocation and protection by αB-crystallin in RPE cells.Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
P2860
Q24799432-32FE44D7-5615-45E8-9000-47A0840F1C80Q30319002-642B5710-7F43-4FED-A6FD-F2EA579E4D55Q30481424-6A30CF4A-19B3-4EC2-8B98-D1E14CD1DB44Q33263714-FAC71CF8-F0EE-40C9-9B43-B46A0457D18EQ33411373-F954C21A-7098-4090-9B5C-2AADB5E36808Q33646877-A8EF4D54-8AA7-4EBD-8E00-460A35280B55Q33931096-CC679157-2A9A-4ED9-B20D-CA82BE697543Q34627867-6730584C-23C1-4326-A48C-5AB1E489333FQ36260036-45282B26-39DB-49B6-BC97-AAF0EE0F9DAEQ36271231-F3C2EA6D-90B7-4611-B9A4-6AD4D5FC5C35Q37154789-E485D0C4-0981-467A-9212-07F777242788Q37241367-312D03D3-CED8-4283-B7D1-6CADE271D68CQ37650629-3B95BDDF-33DC-41B3-B7C8-0A8498C7476BQ37660323-9E80E057-E2E5-42FB-8829-70722667F0B0Q38452625-D6A105D8-6D70-4132-857A-784EB6BF458BQ38511517-4E86D5C6-CF9D-4F60-9C54-6B230F8CEAB5Q38671885-0FA738A8-8644-4FA1-88D0-7947441784F1Q39737951-4E57BF88-3BC8-48CC-A1C1-C96E1C012131Q40047680-B9B7DBC6-160E-4B5D-A6A2-E2768E65449EQ40062235-C18214E9-68FA-481A-9A06-D45D0572EEA9Q42109826-D955C8EC-262E-434A-BEF8-7E6EB4FC36EDQ42276714-F2A4239A-6E8A-4331-92DC-66C36D5B3B7C
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Differential protein profiling in renal-cell carcinoma.
@ast
Differential protein profiling in renal-cell carcinoma.
@en
type
label
Differential protein profiling in renal-cell carcinoma.
@ast
Differential protein profiling in renal-cell carcinoma.
@en
prefLabel
Differential protein profiling in renal-cell carcinoma.
@ast
Differential protein profiling in renal-cell carcinoma.
@en
P2093
P356
P1476
Differential protein profiling in renal-cell carcinoma.
@en
P2093
Andrew C Novick
Joseph A DiDonato
Louis S Liou
Zhong-Hui Duan
P356
10.1002/MC.20015
P577
2004-05-01T00:00:00Z